See also our related blog for the Pediatric Preclinical Testing Initiative.

Saturday, September 25, 2010

Exciting New NCI Award

We are thankful to be one of a handful of recipients of an R01 supplement exceeding $200k in response to the Carolyn Price Walker Act.  This award to our laboratory and the Northwest Sarcoma Foundation is meant to increase awareness of the improved outcomes of childhood cancer patients when treated at specialized, multi-disciplinary centers.  We also have a project to increase awareness of the value of biopsy samples for scientific research when tumors grow despite treatment.  Many thanks to the great number of people on the team at Doernbecher Children's Hospital, Melissa Hill at the Northwest Sarcoma Foundation, and Nancy Goodman of Kids vs Cancer for making this possible.   

COG Fall Meeting

This past week was the Children's Oncology Group Fall meeting.  Normally, the COG meets twice a year to discuss design and results (when available) of the latest clinical trials.  This was a particularly special meeting, in that founding COG Chair, Dr. Gregory Reaman, was recognized for his phenomenal legacy of work with COG & CureSearch, and physician-scientist Dr. Peter Adamson took the leadership position moving forward.  This meeting was well attended by pediatric oncology medical caregivers and the public alike.  Our lab's contributions were a rhabdomyosarcoma presentation to the Soft Tissue Sarcoma Biology Special Session, as well as chairing (with the help of Maryam Fouladi) the CNS new therapeutics session.  
[ above right:  Charles and Ross Vick, advisory director member of QuadW, discussing sarcoma research ]